Roland LANDMAN
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Philippe Van de Perre, MD, PhD
Institut National de la Santé Et de la Recherche Médicale, France
Shared therapeutic areas:
Worked with same sponsors:
Lucy Dorrell
University of Oxford
Shared therapeutic areas:
Nancy Ames, R.N.
National Institutes of Health Clinical Center (CC)
Shared therapeutic areas:
Barney S Graham, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Andrew McMichael
University of Oxford
Shared therapeutic areas:
Haby Sy Signate, MD
Hôpital d'Enfant Albert Royer, Dakar, Senegal
Shared therapeutic areas:
Worked with same sponsors:
Martin R Gaudinski, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Zeda Rosenberg, ScD
Beijing Immupeutics Medicine Technology Limited
Shared therapeutic areas:
Supachai Rerks-Ngarm, MD
Ministry of Health, Thailand
Shared therapeutic areas:
Christian Wejse, MD, PhD
Aarhus University Hospital Skejby
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073
CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)
All 2 trials loaded